UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004504 |
|---|---|
| Receipt number | R000005374 |
| Scientific Title | A phase II study of adjuvant chemotherapy with 5-FU and heparin-based portal infusion chemotherapy followed by gemcitabine for patients with resected pancreatic cancer (TOSPAC-01) |
| Date of disclosure of the study information | 2010/11/15 |
| Last modified on | 2016/05/09 22:04:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/11/04 13:58:49 | ||
| 2 | Update | 2012/02/08 13:56:22 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Name of person sending information Name of person sending information Division name Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/01/07 13:31:43 | UMIN ID1 |
|
| 4 | Update | 2014/11/04 18:11:36 | Recruitment status |
|
| 5 | Update | 2015/04/05 15:34:12 | UMIN ID2 |
|
| 6 | Update | 2015/04/08 11:02:27 | TEL Address Address |
|
| 7 | Update | 2015/11/11 16:12:36 | UMIN ID3 |
|
| 8 | Update | 2016/05/09 22:02:01 | Publication of results |
|
| 9 | Update | 2016/05/09 22:04:13 | UMIN ID3 |
